Feed aggregator
That never happened ... until the postseason
That never happened ... until the postseason
A Cubs repeat? A Bryce bounce-back? Storylines that will shape 2017
A Cubs repeat? A Bryce bounce-back? Storylines that will shape 2017
Former Rangers pitcher Barfield dies in shooting
Former Rangers pitcher Barfield dies in shooting
Wade Davis Q&A: Thoughts on coming to the Cubs and more
Wade Davis Q&A: Thoughts on coming to the Cubs and more
Son: Mel Stottlemyre 'fighting for his life'
Son: Mel Stottlemyre 'fighting for his life'
Report: London calling for Yanks-Red Sox in '18?
Report: London calling for Yanks-Red Sox in '18?
Tigers bring back C Avila on 1-year, $2M deal
Tigers bring back C Avila on 1-year, $2M deal
Source: Angels, OF Revere strike 1-year deal
Source: Angels, OF Revere strike 1-year deal
Tis the season to celebrate 'Feats of Strength'
Tis the season to celebrate 'Feats of Strength'
How the Encarnacion deal finally came together
How the Encarnacion deal finally came together
CF Inciarte, Braves agree to 5-year extension
CF Inciarte, Braves agree to 5-year extension
Which Hall of Fame hopefuls made us say 'wow'?
Which Hall of Fame hopefuls made us say 'wow'?
Indians get a big bat in Encarnacion
Indians get a big bat in Encarnacion
Source: Slugger Encarnacion chooses Indians
Source: Slugger Encarnacion chooses Indians
UCSF Discovery May Lead to New Treatments to Protect Fetus from Deadly Effects of Food Poisoning
A newly identified bacterial protein that is shown to jump-start infection may be the culprit in a foodborne disease that strikes pregnant women in disproportionately high numbers, leading to miscarriage and pre-term birth.
Categories: News
Margot Kushel: Providing the Homeless with Better, More Appropriate Medical Care
Margot Kushel’s research, clinical and personal work with homeless patients stretches back to the 1990s when she was a medical resident at ZSFG.
Categories: News
Will Nova burn as brightly in Pirates return?
Will Nova burn as brightly in Pirates return?
Source: Pirates agree to $26M deal with Nova
Source: Pirates agree to $26M deal with Nova
Positive Multiple Sclerosis Clinical Trial Results Support New Treatment Approach
In findings that show the effectiveness of a new strategy for treating multiple sclerosis, researchers are reporting positive results from three large, international, multicenter Phase III clinical trials of the investigational drug ocrelizumab in both relapsing multiple sclerosis and primary progressive multiple sclerosis.
Categories: News
UCSF Joins Multi-University Collaboration Agreement with Facebook’s Building 8
UCSF is joining a unique collaboration agreement with Facebook that would allow its researchers to engage in joint technology projects without the usual red tape.
Categories: News